ASCO: Alvimopan Helpful for Men Undergoing Testicular CA Surgery

This article originally appeared here.
Share this content:
ASCO: Alvimopan Helpful for Men Undergoing Testicular CA Surgery
ASCO: Alvimopan Helpful for Men Undergoing Testicular CA Surgery

FRIDAY, Feb. 17, 2017 (HealthDay News) -- For men with testicular cancer undergoing retroperitoneal lymph node dissection (RPLND), alvimopan may reduce hospital length of stay (LOS) and enhance gastrointestinal recovery, according to a study presented at the American Society of Clinical Oncology's annual Genitourinary Cancers Symposium, held from Feb. 16 to 18 in Orlando, Fla.

Kushan Dilip Radadia, M.D., from Rutgers Robert Wood Johnson University Hospital in New Brunswick, N.J., and colleagues examined whether alvimopan is associated with enhanced gastrointestinal recovery and shorter LOS in 29 men undergoing RPLND by a single surgeon for testicular cancer. Eight of the participants received alvimopan and 21 did not.

The researchers observed no between-group differences in preoperative or operative variables. Patients receiving alvimopan had a mean hospital length of stay of four days compared with six days among men not receiving alvimopan (P = 0.074). The median time to return of flatus was two and four days for men receiving versus those not receiving alvimopan, respectively (P = 0.0023). The median time to first bowel movement was 2.5 versus four days for those receiving versus not receiving alvimopan (P = 0.0028).

"Strategies that enhance post-surgery recovery, such as the adoption of alvimopan in recovery pathways, may minimize gastrointestinal side effects and shorten the length of hospital stay for these men," a coauthor said in a statement.

Abstract
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Higher Risk of Adverse Outcomes for Births to Young CA Survivors

Higher Risk of Adverse Outcomes for Births to ...

Increased risks among live births for adolescent and young adult cancer survivors

Many Youths With Diabetes Not Receiving Eye Examinations

Many Youths With Diabetes Not Receiving Eye Examinations

Racial minorities less likely to undergo eye exam; increasing net worth increases likelihood of eye exam

Mortality Risk Impacts Colon CA Screening in Dialysis Patients

Mortality Risk Impacts Colon CA Screening in Dialysis ...

Higher rate of screening among patients most likely to receive a transplant

is free, fast, and customized just for you!

Already a member?

Sign In Now »